x
Filter:
Filters applied
- Free Access
- DiscussionRemove Discussion filter
Publication Date
Please choose a date range between 2010 and 2020.
Author
- Gleicher, Norbert4
- Barad, David H2
- Bruce, Alexander W2
- Kushnir, Vitaly A2
- Acharya, Santanu1
- Adashi, Eli Y1
- Afnan, Masoud AM1
- Agerholm, Inge1
- Alikani, Mina1
- Altmäe, Signe1
- Badeghiesh, Ahmad1
- Bahadur, Gulam1
- Baylis, Françoise1
- Benagiano, Giuseppe1
- Bennett, Fiona1
- Bentin-Ley, Ursula1
- Bento, Fabiola C1
- Berend, Zsuzsa1
- Besser, Andria G1
- Boivin, J1
- Bosch, Ernesto1
- Brown, Brandon1
- Bunnell, Megan1
- Bunting, L1
- Burton, Graham J1
Keyword
- IVF9
- infertility6
- ethics5
- assisted reproduction4
- HFEA3
- surrogacy3
- COVID-192
- gamete donation2
- Infertility2
- oocyte donation2
- Ovarian hyperstimulation syndrome2
- premenopause2
- regulation2
- sex education2
- 2PN1
- Allantois1
- Amnion1
- Anaemic zone1
- Arm's Length Bodies review1
- ART1
- ART complications1
- ART utilization1
- Artificial intelligence1
- Assisted reproductive technologies1
- BRCA2 mutation1
Free Access Articles
64 Results
- VIEWPOINT
Reproductive technology and social justice: a view from Brazil
Reproductive BioMedicine OnlineVol. 41Issue 6p1151–1153Published in issue: December, 2020- Marilena Correa
- Ilana Löwy
Cited in Scopus: 1Debates on the practical and ethical dilemmas produced by the rapid changes in assisted reproductive technology (ART) are frequently focused on the consequences of new developments in Western Europe and North America. Discussions about ART in developing and middle-income countries tend to be centred on the use – and for some, the possible exploitation – of women's bodies as sources of biological materials and providers of services. They more rarely examine patterns of implementation of ART in these countries. - Commentary
A revolutionary joins the establishment: Reproductive Biomedicine Online turns 20
Reproductive BioMedicine OnlineVol. 41Issue 6p978–980Published online: September 1, 2020- Fiona Bennett
Cited in Scopus: 0This commentary highlights the publishing revolution achieved by Robert Edwards in founding Reproductive Biomedicine Online. It corrects some inaccuracies in the account given by Roger Gosden in his recently published book Let There Be Life: An Intimate Portrait of Robert Edwards and His IVF Revolution. - Commentary
Preimplantation genetic testing as a component of root cause analysis of errors and reassignment of embryos in IVF
Reproductive BioMedicine OnlineVol. 41Issue 6p975–977Published online: August 26, 2020- Megan Bunnell
- Navid Esfandiari
Cited in Scopus: 0The risks of embryo/gamete mix-up are a threat to the integrity of the IVF process, with significant implications for affected families. The use of preimplantation genetic testing through single-nucleotide polymorphism array or next-generation sequencing technology can help to identify, characterize and ultimately help, in some cases, to find the root cause, and to mitigate the extent of these errors for a given patient or laboratory. - CommentaryOpen Access
Empathetic application of machine learning may address appropriate utilization of ART
Reproductive BioMedicine OnlineVol. 41Issue 4p573–577Published online: July 14, 2020- Julian Jenkins
- Sheryl van der Poel
- Jan Krüssel
- Ernesto Bosch
- Scott M. Nelson
- Anja Pinborg
- and others
Cited in Scopus: 5The value of artificial intelligence to benefit infertile patients is a subject of debate. This paper presents the experience of one aspect of artificial intelligence, machine learning, coupled with patient empathy to improve utilization of assisted reproductive technology (ART), which is an important aspect of care that is under-recognized. Although ART provides very effective options for infertile patients to build families, patients often discontinue ART when further treatment is likely to be beneficial and most of these patients do not achieve pregnancy without medical aid. - Commentary
Reproductive healthcare during a pandemic: a New York state of mind
Reproductive BioMedicine OnlineVol. 41Issue 3p370–372Published online: June 16, 2020- Vitaly A. Kushnir
- Banafsheh Kashani
- Eli Y. Adashi
Cited in Scopus: 1The purpose of this Commentary is to assess whether the designation by New York State Department of Health of ‘sexual and reproductive health services as essential’ is consonant with the seemingly divergent objectives of providing patient-centred care and advancing national public health objectives in the resource-constrained setting of a global pandemic. - commentary
Trends in ovarian hyperstimulation syndrome hospitalization rates in the USA: an ongoing concern
Reproductive BioMedicine OnlineVol. 41Issue 3p357–360Published online: June 15, 2020- Keren Rotshenker-Olshinka
- Ahmad Badeghiesh
- Alexander Volodarsky-Perel
- Naama Steiner
- Eva Suarthana
- Michael H Dahan
Cited in Scopus: 8Ovarian hyperstimulation syndrome (OHSS) is a serious, almost exclusively, iatrogenic complication of ovarian stimulation. Many techniques have been developed over the past 25 years to decrease OHSS risks, and most have been in common use for 15–20 years. In view of these techniques, it could be hypothesized that severe OHSS rates would decrease or almost disappear. According to the US National ART Surveillance System, rates did not change significantly between 2000 and 2009, at 106 OHSS cases per 10,000 IVF cycles annually. - Commentary
SARS-CoV-2: diagnostic and design conundrums in the context of male factor infertility
Reproductive BioMedicine OnlineVol. 41Issue 3p365–369Published online: June 2, 2020- Gulam Bahadur
- Santanu Acharya
- Asif Muneer
- Judith Huirne
- Mariusz Łukaszuk
- Pablo Alexis Doreski
- and others
Cited in Scopus: 6The question of whether SARS-CoV-2 (severe acute respiratory syndrome-related coronavirus-2 [SARS-CoV-2], leading to the COVID-19 infection) can be harboured in the testes and/or semen is currently unanswered. It is essential to understand the limitations of both antibody and real-time PCR tests in interpreting SARS-CoV-2 data in relation to analyses of semen and testicular tissue without appropriate controls. This article critically analyses the evidence so far on this, and the possible implications. - Commentary
Generating translatable evidence to improve patient care: the contribution of human factors
Reproductive BioMedicine OnlineVol. 41Issue 3p353–356Published online: May 10, 2020- Masoud A.M. Afnan
- Khalid Saeed Khan
- Ben Willem Mol
Cited in Scopus: 4Generating translatable evidence to improve patient care has proved challenging in reproductive medicine, with many ‘add-on’ treatments in routine assisted conception clinical practice that have not been reliably tested. This has consequences for patient care; specifically, IVF pregnancy rates have not improved. A change of culture is required in our profession, from indiscriminately applying the latest ‘add-on’ to large-scale participation in generating reliable translatable evidence. - Commentary
Advanced fibroid study: paying homage to John Sampson
Reproductive BioMedicine OnlineVol. 39Issue 2p183–186Published online: April 25, 2019- John L Yovich
- Philip K Rowlands
- Sunthra Lingam
- Mark Sillender
- Shanthi Srinivasan
Cited in Scopus: 3A recent article supports our longstanding view that all intramural fibroids can cause disturbance of uterine function. This may be reflected in the symptom of menorrhagia or fertility-related issues, as well as pregnancy losses at all gestational stages. However, it was disappointing that there was no reference to either the mechanism by which fibroids disturb uterine function nor to the gynaecologist who described this more than 100 years ago, namely John Sampson. In fact, Sampson's findings about the unique venous drainage mechanism from the endometrium explains how menstrual loss is contained in normal physiology, but which can be excessive when the protective ‘anaemic’ zone is disturbed. - Commentary
A demographic projection of the contribution of assisted reproductive technologies to world population growth
Reproductive BioMedicine OnlineVol. 36Issue 4p455–458Published online: February 1, 2018- Malcolm J. Faddy
- Matthew D. Gosden
- Roger G. Gosden
Cited in Scopus: 49Enormous unmet needs for infertility treatment exist because access to assisted reproductive technologies is demographically skewed. Since the first IVF baby in 1978, the number of people conceived by reproductive technology has grown much faster than expected, reaching several million today and rapidly approaching 0.1% of the total world population. As more patients build families, and their children in turn become parents, the number owing their existence to assisted reproductive technologies, either directly or indirectly, will expand tremendously in future decades, but no attempts have been made hitherto to project the magnitude. - Commentary
Dignity again
Reproductive BioMedicine OnlineVol. 36Issue 3p285–287Published online: December 7, 2017- Alain Pottage
Cited in Scopus: 4Two recent contributions to this journal discuss a challenge to Stanford's time-lapse embryo monitoring patent, currently before the European Patent Office (EPO). Sterckx, Cockbain and Pennings (2017) would like to keep the morphokinetics of embryo division in the public domain; they argue that time-lapse monitoring (TLM) is a diagnostic method in the sense of European patent law and therefore unpatentable. In response, Pearce (2017) suggests that the jurisprudence of the EPO unambiguously says that TLM is not a diagnostic method. - Commentary
Comments on the ESHRE recommendations for the treatment of minimal endometriosis in infertile women
Reproductive BioMedicine OnlineVol. 36Issue 1p84–87Published online: October 23, 2017- Angelos Daniilidis
- George Pados
Cited in Scopus: 7According to ESHRE recommendations for women with stage I/II endometriosis, if a decision is made to proceed to laparoscopy then operative laparoscopy (excision or ablation of the endometriotic lesions) should be performed rather than only diagnostic laparoscopy, to increase ongoing pregnancy rates. Also, for infertile women with stage I/II endometriosis doctors may consider complete surgical removal of endometriosis to improve live birth rate prior to assisted reproductive treatment. This last recommendation is not well established. - Commentary
Extragonadal primordial germ cells or placental progenitor cells?
Reproductive BioMedicine OnlineVol. 36Issue 1p6–11Published online: October 13, 2017- Karen M. Downs
Cited in Scopus: 3Primordial germ cells (PGCs), the precursors of the gametes, are now claimed to segregate within the extra-embryonic tissues of three species of placental mammals. In this brief Commentary, I raise the question of whether the so-called PGCs are not PGCs at all, but rather, progenitor cells that build the fetal–placental interface in Placentalia. - Commentary
GnRHa trigger and luteal coasting: a new approach for the ovarian hyperstimulation syndrome high-risk patient?
Reproductive BioMedicine OnlineVol. 36Issue 1p75–77Published online: October 13, 2017- Barbara Lawrenz
- Peter Humaidan
- Shahar Kol
- Human M. Fatemi
Cited in Scopus: 9Final oocyte maturation using gonadotrophin-releasing hormone agonist (GnRHa) is increasingly common as it almost eliminates the risk of developing ovarian hyperstimulation syndrome (OHSS) in high-responder patients. The first studies using this approach showed a poor reproductive outcome when only vaginal progesterone was used as luteal phase support, due to the luteolysis that will develop as a result of LH withdrawal. Timely luteal administration of human chorionic gonadotrophin (HCG) will counterbalance the low LH concentrations and therefore maintain progesterone production from the corpora lutea, however, some patients with a high number of follicles will develop OHSS using this approach. - Commentary
A clinical assay for reactive oxygen species – ready for primetime?
Reproductive BioMedicine OnlineVol. 36Issue 1p88–89Published online: October 5, 2017- Christopher J. De Jonge
Cited in Scopus: 1Reactive oxygen species (ROS) have been demonstrated to have damaging effects on human sperm function. The measurement of ROS as an adjunct to traditional semen analysis has clinical relevance as part of the diagnosis of male infertility. The assay best suited to the clinical laboratory environment for detecting ROS generation remains somewhat controversial. A recent report on a multicenter study evaluating the reduction of nitroblue tetrazolium (NBT) to formazan precipitate as an indirect reporter of ROS-generating activity in spermatozoa, seminal plasma and semen has received a critique raising questions as to the sensitivity and specificity of the assay for detecting ROS. - Commentary
Chimeras intended for human gamete production: an ethical alternative?
Reproductive BioMedicine OnlineVol. 35Issue 4p387–390Published online: July 18, 2017- César Palacios-González
Cited in Scopus: 4Human eggs for basic, fertility and stem-cell research are in short supply. Many experiments that require their use cannot be carried out at present, and, therefore, the benefits that could emerge from these are either delayed or never materialise. This state of affairs is problematic for scientists and patients worldwide, and it is a matter that needs our attention. Recent advances in chimera research have opened the possibility of creating human/non-human animal chimeras intended for human gamete production (chimeras-IHGP). - Commentary
Counselling considerations for chromosomal mosaicism detected by preimplantation genetic screening
Reproductive BioMedicine OnlineVol. 34Issue 4p369–374Published online: January 14, 2017- Andria G. Besser
- Emily L. Mounts
Cited in Scopus: 32The evolution of preimplantation genetic screening (PGS) for aneuploidy to blastocyst biopsy and more sensitive 24-chromosome screening techniques has resulted in a new diagnostic category of PGS results: those classified as mosaic. This diagnosis presents significant challenges for clinicians in developing policies regarding transfer and storage of such embryos, as well as in providing genetic counselling for patients prior to and following PGS. Given the high frequency of mosaic PGS results and the wide range of possible associated outcomes, there is an urgent need to understand how to appropriately counsel patients regarding such embryos. - Commentary
Baby factories taint surrogacy in Nigeria
Reproductive BioMedicine OnlineVol. 32Issue 1p6–8Published online: October 14, 2015- Olusesan Ayodeji Makinde
- Olufunmbi Olukemi Makinde
- Olalekan Olaleye
- Brandon Brown
- Clifford O. Odimegwu
Cited in Scopus: 11The practice of reproductive medicine in Nigeria is facing new challenges with the proliferation of ‘baby factories’. Baby factories are buildings, hospitals or orphanages that have been converted into places for young girls and women to give birth to children for sale on the black market, often to infertile couples, or into trafficking rings. This practice illegally provides outcomes (children) similar to surrogacy. While surrogacy has not been well accepted in this environment, the proliferation of baby factories further threatens its acceptance. - Commentary
Implementation of cleanroom technology in reproductive laboratories: the question is not why but how
Reproductive BioMedicine OnlineVol. 32Issue 1p9–11Published online: October 13, 2015- Sandro C. Esteves
- Fabiola C. Bento
Cited in Scopus: 7Two articles recently published in Reproductive BioMedicine Online described how fertility centres in the USA and Brazil implemented air quality control to newly designed facilities. In both case scenarios, a highly efficient air filtration was achieved by installing a centred system supplying filtered air to the IVF laboratory and other critical areas, combining air particulate and volatile organic compound (VOC) filtration. Evaluating retrospective data of over 3000 cycles from both centres, live birth rates were increased by improvements in air quality and laboratory environment. - CommentaryOpen Access
Cryopreservation and transplantation of ovarian tissue exclusively to postpone menopause: technically possible but endocrinologically doubtful
Reproductive BioMedicine OnlineVol. 31Issue 6p718–721Published online: August 21, 2015- Michael von Wolff
- Petra Stute
Cited in Scopus: 12Transplantation of cryopreserved ovarian tissue has been shown to induce pregnancies and puberty successfully. Therefore, using cryopreserved ovarian tissue to postpone menopause (tissue hormone therapy [THT]) seems to be an interesting option to avoid conventional menopause hormone therapy (MHT). Pregnancy induction and replacing MHT by THT, however, are completely different topics as different requirements need to be met. First, MHT requires long-lasting and continuous hormone production. It still needs to be proven if the transplanted tissue is active for at least 5 years with a continuous follicle growth to avoid phases with low oestrogen production, which would otherwise cause menopausal symptoms and could reduce the postulated benefit for women's health. - CommentaryOpen Access
To pill or not to pill in GnRH-antagonist cycles: the answer is in the data already!
Reproductive BioMedicine OnlineVol. 31Issue 1p6–8Published online: April 9, 2015- Georg Griesinger
- Christos A. Venetis
- Basil Tarlatzis
- Efstratios Michaelis Kolibianakis
Cited in Scopus: 14The planning of IVF treatment by scheduling menstruation and hence initiation of ovarian stimulation using sex-steroid pre-treatment is commonly used. Pooling data from six randomized-controlled trials encompassing 1343 patients, with and without combined oral contraceptive pill pre-treatment, suggests that the ongoing pregnancy rate per randomized woman is significantly lower in patients with oral contraceptive pill pre-treatment (relative risk [RR]: 0.80, 95% confidence interval [CI]: 0.66–0.97; rate difference [RD]: −5%, 95% CI: −10% to −1%; fixed effects model). - CommentaryOpen Access
Implications of the legalization of non-commercial surrogacy for local kinship and motherhood in Vietnamese society
Reproductive BioMedicine OnlineVol. 30Issue 2p113–114Published online: November 7, 2014- Yuri Hibino
Cited in Scopus: 3Until recently, surrogacy was banned in Vietnam for all cases. The government, however, has altered its position on reproductive technology and will soon legalize non-commercial surrogacy among relatives. Motherhood is highly venerated in Vietnamese society and, under this local kinship conception, gestational process is of paramount importance in establishing a connection between the fetus and the woman. The implications of this new government decision for local kinship, motherhood and the individuals concerned will be discussed. - CommentaryOpen Access
Dual ovarian stimulation is a new viable option for enhancing the oocyte yield when the time for assisted reproductive technnology is limited
Reproductive BioMedicine OnlineVol. 29Issue 6p659–661Published online: September 5, 2014- Rebecca Moffat
- Paul Pirtea
- Vanessa Gayet
- Jean Philippe Wolf
- Charles Chapron
- Dominique de Ziegler
Cited in Scopus: 34Ovarian stimulation improves assisted reproductive technology outcome by increasing the number of oocytes available for insemination and in-vitro handling. A recent Duplex protocol features a dual stimulation, with the second stimulation started immediately after the first oocyte retrieval. Remarkably, the Duplex protocol is unexpectadly well tolerated by women and provides twice as many oocytes and embryos as a regular antagonist protocol in less than 30 days. - CommentaryOpen Access
Italian Constitutional Court removes the prohibition on gamete donation in Italy
Reproductive BioMedicine OnlineVol. 29Issue 6p662–664Published online: September 5, 2014- Giuseppe Benagiano
- Valentina Filippi
- Serena Sgargi
- Luca Gianaroli
Cited in Scopus: 18In 2004, The Italian Constitutional Court prohibited treatments involving gamate donation, embryo donation, embryo cryopreservation (except under exceptional circumstances), and the transfer of more than three embryos. Basically three statements were made by the Court: the ban violates a couple's fundamental right to health, to self-determination and to have a child. Here, the consequences of such a decision and the legal challenges that ensued are discussed. - CommentaryOpen Access
Ovarian reserve screening before contraception?
Reproductive BioMedicine OnlineVol. 29Issue 5p527–529Published online: August 6, 2014- Vitaly A. Kushnir
- David H. Barad
- Norbert Gleicher
Cited in Scopus: 13Women are increasingly delaying conception to later years. Hormonal contraception induces artificial cyclicity, which does not, like natural cyclicity, reflect normal, physiological ovarian behaviour. Therefore, long-term users of hormonal contraceptives, in particular, fail to derive potential diagnostic benefits from changes in menstrual cyclicity, which usually alerts patients and physicians to developing ovarian pathology. Timely diagnosis of ovarian problems is further hampered, as anti-Müllerian hormone is suppressed by hormonal contraceptives, making the accurate assessment of functional ovarian reserve more difficult.